List of Contents

miRNA Tools And Services Market Size, Share, and Trends 2024 to 2034

The global miRNA tools market size was USD 383.91 million in 2023, estimated at USD 455.70 million in 2024 and is anticipated to reach around USD 2432.31 million by 2034, expanding at a CAGR of 18.23% from 2024 to 2034.

  • Last Updated : September 2024
  • Report Code : 3633
  • Category : Healthcare

 

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on MiRNA Tools and Services Market 

5.1. COVID-19 Landscape: MiRNA Tools and Services Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global MiRNA Tools and Services Market, By Product and Services

8.1. MiRNA Tools and Services Market, by Product and Services, 2024-2034

8.1.1 Research Tools

8.1.1.1. Market Revenue and Forecast (2021-2034)

8.1.2. Services

8.1.2.1. Market Revenue and Forecast (2021-2034)

Chapter 9. Global MiRNA Tools and Services Market, By Technology

9.1. MiRNA Tools and Services Market, by Technology, 2024-2034

9.1.1. Extraction Tools

9.1.1.1. Market Revenue and Forecast (2021-2034)

9.1.2. qRT-PCR

9.1.2.1. Market Revenue and Forecast (2021-2034)

9.1.3. NGS

9.1.3.1. Market Revenue and Forecast (2021-2034)

9.1.4. Microarray

9.1.4.1. Market Revenue and Forecast (2021-2034)

9.1.5. Functional Analysis Tools

9.1.5.1. Market Revenue and Forecast (2021-2034)

9.1.6. Others

9.1.6.1. Market Revenue and Forecast (2021-2034)

Chapter 10. Global MiRNA Tools and Services Market, By End User 

10.1. MiRNA Tools and Services Market, by End User, 2024-2034

10.1.1. Research and Academic Institutes

10.1.1.1. Market Revenue and Forecast (2021-2034)

10.1.2. IVD, Pharma and Biotech Companies

10.1.2.1. Market Revenue and Forecast (2021-2034)

10.1.3. CROs

10.1.3.1. Market Revenue and Forecast (2021-2034)

Chapter 11. Global MiRNA Tools and Services Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Product and Services (2021-2034)

11.1.2. Market Revenue and Forecast, by Technology (2021-2034)

11.1.3. Market Revenue and Forecast, by End User (2021-2034)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Product and Services (2021-2034)

11.1.4.2. Market Revenue and Forecast, by Technology (2021-2034)

11.1.4.3. Market Revenue and Forecast, by End User (2021-2034)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Product and Services (2021-2034)

11.1.5.2. Market Revenue and Forecast, by Technology (2021-2034)

11.1.5.3. Market Revenue and Forecast, by End User (2021-2034)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Product and Services (2021-2034)

11.2.2. Market Revenue and Forecast, by Technology (2021-2034)

11.2.3. Market Revenue and Forecast, by End User (2021-2034)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Product and Services (2021-2034)

11.2.4.2. Market Revenue and Forecast, by Technology (2021-2034)

11.2.4.3. Market Revenue and Forecast, by End User (2021-2034)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Product and Services (2021-2034)

11.2.5.2. Market Revenue and Forecast, by Technology (2021-2034)

11.2.5.3. Market Revenue and Forecast, by End User (2021-2034)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Product and Services (2021-2034)

11.2.6.2. Market Revenue and Forecast, by Technology (2021-2034)

11.2.6.3. Market Revenue and Forecast, by End User (2021-2034)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Product and Services (2021-2034)

11.2.7.2. Market Revenue and Forecast, by Technology (2021-2034)

11.2.7.3. Market Revenue and Forecast, by End User (2021-2034)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Product and Services (2021-2034)

11.3.2. Market Revenue and Forecast, by Technology (2021-2034)

11.3.3. Market Revenue and Forecast, by End User (2021-2034)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Product and Services (2021-2034)

11.3.4.2. Market Revenue and Forecast, by Technology (2021-2034)

11.3.4.3. Market Revenue and Forecast, by End User (2021-2034)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Product and Services (2021-2034)

11.3.5.2. Market Revenue and Forecast, by Technology (2021-2034)

11.3.5.3. Market Revenue and Forecast, by End User (2021-2034)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Product and Services (2021-2034)

11.3.6.2. Market Revenue and Forecast, by Technology (2021-2034)

11.3.6.3. Market Revenue and Forecast, by End User (2021-2034)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Product and Services (2021-2034)

11.3.7.2. Market Revenue and Forecast, by Technology (2021-2034)

11.3.7.3. Market Revenue and Forecast, by End User (2021-2034)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Product and Services (2021-2034)

11.4.2. Market Revenue and Forecast, by Technology (2021-2034)

11.4.3. Market Revenue and Forecast, by End User (2021-2034)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Product and Services (2021-2034)

11.4.4.2. Market Revenue and Forecast, by Technology (2021-2034)

11.4.4.3. Market Revenue and Forecast, by End User (2021-2034)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Product and Services (2021-2034)

11.4.5.2. Market Revenue and Forecast, by Technology (2021-2034)

11.4.5.3. Market Revenue and Forecast, by End User (2021-2034)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Product and Services (2021-2034)

11.4.6.2. Market Revenue and Forecast, by Technology (2021-2034)

11.4.6.3. Market Revenue and Forecast, by End User (2021-2034)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Product and Services (2021-2034)

11.4.7.2. Market Revenue and Forecast, by Technology (2021-2034)

11.4.7.3. Market Revenue and Forecast, by End User (2021-2034)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Product and Services (2021-2034)

11.5.2. Market Revenue and Forecast, by Technology (2021-2034)

11.5.3. Market Revenue and Forecast, by End User (2021-2034)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Product and Services (2021-2034)

11.5.4.2. Market Revenue and Forecast, by Technology (2021-2034)

11.5.4.3. Market Revenue and Forecast, by End User (2021-2034)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Product and Services (2021-2034)

11.5.5.2. Market Revenue and Forecast, by Technology (2021-2034)

11.5.5.3. Market Revenue and Forecast, by End User (2021-2034)

Chapter 12. Company Profiles

12.1. Thermo Fisher Scientific

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Agilent Technologies

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Qiagen

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Illumina, Inc.

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Bio-Rad Laboratories, Inc.

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Merck KGaA

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. PerkinElmer, Inc.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Takara Bio Inc.

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. New England Biolabs

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. NanoString Technologies, Inc.

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

 

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client